- Home
- WHLRD vs SVA Comparison
WHLRD vs SVA Comparison
Compare WHLRD & SVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHLRD
- SVA
- Stock Information
- Founded
- WHLRD N/A
- SVA N/A
- Country
- WHLRD United States
- SVA
- Employees
- WHLRD 52
- SVA 3261
- Industry
- WHLRD Real Estate Investment Trusts
- SVA
- Sector
- WHLRD Real Estate
- SVA
- Exchange
- WHLRD Nasdaq
- SVA NYSE
- Market Cap
- WHLRD N/A
- SVA N/A
- IPO Year
- WHLRD N/A
- SVA N/A
- Fundamental
- Price
- WHLRD $25.79
- SVA $6.47
- Analyst Decision
- WHLRD
- SVA
- Analyst Count
- WHLRD 0
- SVA 0
- Target Price
- WHLRD N/A
- SVA N/A
- AVG Volume (30 Days)
- WHLRD N/A
- SVA N/A
- Earning Date
- WHLRD N/A
- SVA N/A
- Dividend Yield
- WHLRD N/A
- SVA N/A
- EPS Growth
- WHLRD N/A
- SVA N/A
- EPS
- WHLRD N/A
- SVA N/A
- Revenue
- WHLRD N/A
- SVA N/A
- Revenue This Year
- WHLRD N/A
- SVA N/A
- Revenue Next Year
- WHLRD N/A
- SVA N/A
- P/E Ratio
- WHLRD N/A
- SVA N/A
- Revenue Growth
- WHLRD N/A
- SVA N/A
- 52 Week Low
- WHLRD N/A
- SVA N/A
- 52 Week High
- WHLRD N/A
- SVA N/A
- Technical
- Relative Strength Index (RSI)
- WHLRD 53.34
- SVA N/A
- Support Level
- WHLRD $24.10
- SVA N/A
- Resistance Level
- WHLRD $26.40
- SVA N/A
- Average True Range (ATR)
- WHLRD 0.73
- SVA 0.00
- MACD
- WHLRD 0.05
- SVA 0.00
- Stochastic Oscillator
- WHLRD 74.04
- SVA 0.00
About WHLRD Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.